# Novo Nordisk a S: financial statements, quarterly

NVO · NYSE · CIK 353278 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nvo.md) · [Financials](/companies/nvo/financials.md) · [Filings](/companies/nvo/filings.md) · [Insiders](/companies/nvo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nvo/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2018-12-31) | period not labelled (2019-12-31) | period not labelled (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [15.6](/filings/0001628280-22-001639.md) | [15.4](/filings/0001628280-23-001868.md) | [12.2](/filings/0001628280-24-002635.md) | [10.7](/filings/0001628280-25-003920.md) | [12.7](/filings/0000353278-26-000012.md) | [14.4](/filings/0000353278-26-000012.md) | [15.7](/filings/0000353278-26-000012.md) | [26.5](/filings/0000353278-26-000012.md) |
| Current assets | $bn | not reported | not reported | [65.8](/filings/0001628280-22-001639.md) | [85.6](/filings/0001628280-23-001868.md) | [108](/filings/0001628280-24-002635.md) | [140](/filings/0001628280-25-003920.md) | [162](/filings/0000353278-26-000012.md) | [172](/filings/0000353278-26-000012.md) |
| Total assets | $bn | not reported | not reported | [145](/filings/0001628280-22-001639.md) | [195](/filings/0001628280-23-001868.md) | [241](/filings/0001628280-24-002635.md) | [314](/filings/0001628280-25-003920.md) | [466](/filings/0000353278-26-000012.md) | [543](/filings/0000353278-26-000012.md) |
| Current liabilities | $bn | not reported | not reported | [70.3](/filings/0001628280-22-001639.md) | [99.5](/filings/0001628280-23-001868.md) | [121](/filings/0001628280-24-002635.md) | [170](/filings/0001628280-25-003920.md) | [218](/filings/0000353278-26-000012.md) | [216](/filings/0000353278-26-000012.md) |
| Total liabilities | $bn | not reported | not reported | [81.6](/filings/0001628280-22-001639.md) | [124](/filings/0001628280-23-001868.md) | [158](/filings/0001628280-24-002635.md) | [208](/filings/0001628280-25-003920.md) | [322](/filings/0000353278-26-000012.md) | [349](/filings/0000353278-26-000012.md) |
| Shareholders' equity | $bn | [51.8](/filings/0001628280-22-001639.md) | [57.6](/filings/0001628280-23-001868.md) | [63.3](/filings/0001628280-24-002635.md) | [70.7](/filings/0001628280-25-003920.md) | [83.5](/filings/0000353278-26-000012.md) | [107](/filings/0000353278-26-000012.md) | [143](/filings/0000353278-26-000012.md) | [194](/filings/0000353278-26-000012.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.